Analysts Set DocGo Inc. (NASDAQ:DCGO) Price Target at $3.21

DocGo Inc. (NASDAQ:DCGO) has earned an average recommendation of “Hold” from the seven analysts that are covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and two have assigned a buy recommendation to the company. The average twelve-month target price among analysts that have covered the stock in the last year is $3.2125.

A number of analysts have issued reports on the stock. Canaccord Genuity Group cut their price objective on shares of DocGo from $1.60 to $1.50 and set a “buy” rating for the company in a report on Wednesday, November 12th. Zacks Research raised DocGo from a “strong sell” rating to a “hold” rating in a research report on Thursday, November 6th. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of DocGo in a report on Monday, December 29th.

Institutional Trading of DocGo

Several large investors have recently made changes to their positions in DCGO. JPMorgan Chase & Co. raised its position in DocGo by 92.0% during the third quarter. JPMorgan Chase & Co. now owns 557,613 shares of the company’s stock valued at $758,000 after purchasing an additional 267,259 shares in the last quarter. Voleon Capital Management LP bought a new position in shares of DocGo in the 3rd quarter valued at $195,000. Millennium Management LLC raised its holdings in shares of DocGo by 878.6% during the 3rd quarter. Millennium Management LLC now owns 766,210 shares of the company’s stock worth $1,042,000 after buying an additional 687,911 shares in the last quarter. Bridgeway Capital Management LLC raised its holdings in shares of DocGo by 3.6% during the 3rd quarter. Bridgeway Capital Management LLC now owns 370,699 shares of the company’s stock worth $504,000 after buying an additional 12,942 shares in the last quarter. Finally, BNP Paribas Financial Markets lifted its position in shares of DocGo by 411.3% during the 3rd quarter. BNP Paribas Financial Markets now owns 81,482 shares of the company’s stock worth $111,000 after buying an additional 65,545 shares during the last quarter. Institutional investors and hedge funds own 56.44% of the company’s stock.

DocGo Price Performance

DCGO opened at $0.85 on Monday. The business has a fifty day simple moving average of $0.94 and a 200 day simple moving average of $1.24. DocGo has a 1 year low of $0.81 and a 1 year high of $5.68. The company has a market capitalization of $83.30 million, a PE ratio of -1.64 and a beta of 0.94.

DocGo (NASDAQ:DCGO) last posted its earnings results on Monday, November 10th. The company reported ($0.11) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.09) by ($0.02). The firm had revenue of $70.81 million for the quarter, compared to analyst estimates of $69.96 million. DocGo had a negative return on equity of 9.11% and a negative net margin of 14.02%. Equities analysts anticipate that DocGo will post 0.25 earnings per share for the current fiscal year.

DocGo Company Profile

DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.

In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.